tiprankstipranks
Trending News
More News >
Hygrovest Limited (AU:UWC)
ASX:UWC

Hygrovest Limited (UWC) AI Stock Analysis

Compare
2 Followers

Top Page

AU:UWC

Hygrovest Limited

(Sydney:UWC)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
AU$0.05
▼(-15.00% Downside)
Action:ReiteratedDate:03/03/26
The score is driven mainly by solid financial resilience (no debt, stable equity) and improving 2025 fundamentals (positive net income and free cash flow), offset by weak technicals (below key moving averages, negative MACD and oversold momentum) and an operating profitability concern (still-negative EBITDA). Valuation is supportive due to a low P/E.
Positive Factors
Debt-free balance sheet
Zero reported debt and a stable ~A$19M equity base materially lower financial risk and preserve strategic optionality. Over a 2–6 month horizon this durability supports capital allocation for growth or cushioning against shocks while management executes operating improvements.
Positive operating and free cash flow (2025)
The move to positive operating and free cash flow in 2025 marks a structural inflection in cash generation. If maintained, this underpins reinvestment, reduces refinancing risk and signals improving cash conversion that is more durable than one-off accounting gains.
Top-line recovery and net income return
Meaningful revenue growth and a return to positive net income indicate improving market traction and scale. Sustained top-line momentum combined with net profits enhances long-term free cash flow potential and validates recovery of the underlying business model.
Negative Factors
Persistent negative EBITDA
Continued negative EBITDA shows operating margins remain structurally weak despite revenue growth. This implies the core business still needs efficiency improvements to convert sales into sustainably positive operating profits and cash generation over the medium term.
Volatile historical cash flows
Prior years of large cash burn highlight execution risk and variability in cash conversion. While 2025 improved, the inconsistency raises concerns about repeatability of cash generation and the reliability of funding growth or dividends without structural fixes.
Low returns on equity/assets
ROE moving from negative to marginally positive still reflects weak capital efficiency. The existing asset base is not producing compelling returns, limiting reinvestment capacity and signaling that further operational or strategic change is needed to lift long-term profitability.

Hygrovest Limited (UWC) vs. iShares MSCI Australia ETF (EWA)

Hygrovest Limited Business Overview & Revenue Model

Company DescriptionUnderwood Capital Limited operates as a specialist investment company. The company focuses on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and debt securities. The company was formerly known as Hygrovest Limited and changed its name to Underwood Capital Limited in December 2024. Underwood Capital Limited was incorporated in 2014 and is based in Sydney, Australia.
How the Company Makes Money

Hygrovest Limited Financial Statement Overview

Summary
Balance sheet strength (zero debt and stable equity base) supports resilience, but operating performance remains mixed: revenue improved and net income turned positive in 2025, while EBITDA is still negative and historical earnings/cash flows have been volatile. Cash flow improved to positive operating and free cash flow in 2025, but consistency is not yet proven.
Income Statement
42
Neutral
Revenue has grown meaningfully in the latest annual period (2025 vs. 2024), and the company returned to positive net income in 2025 after losses in 2024 and 2023. Gross profit is strong relative to revenue, but operating profitability remains a key weakness: EBITDA is negative in both 2025 and 2024, and the business showed very large losses in 2023 (and materially worse in 2020). Overall, the earnings profile looks volatile with improving top-line momentum but still-challenged underlying operating performance.
Balance Sheet
78
Positive
The balance sheet is a clear strength: total debt is reported as zero across all shown annual periods, and equity remains substantial and stable (roughly $19M in 2023–2025) relative to total assets. Return on equity has improved from materially negative in 2023 to slightly positive in 2025, but the low level of returns suggests the asset base is not yet generating strong profitability. Net-net, low leverage reduces financial risk, though returns remain modest.
Cash Flow
47
Neutral
Cash generation has improved sharply in the latest annual period: operating cash flow and free cash flow turned positive in 2025 after significant cash burn in 2024 and negative free cash flow in 2023 and 2020. That said, the prior-year drawdowns highlight volatility and execution risk, and the provided cash-flow-to-earnings style ratios are not informative (reported as 0.0), limiting visibility into cash earnings quality. Overall, the trajectory is improving but consistency is not yet proven.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2019Jun 2018
Income Statement
Total Revenue211.00K540.00K206.00K187.00K0.00211.00K
Gross Profit-4.02M540.00K206.00K187.00K-10.00K-4.02M
EBITDA3.86M-808.00K-844.00K-1.58M-42.89M3.86M
Net Income5.14M243.00K-131.00K-3.98M-40.08M5.14M
Balance Sheet
Total Assets65.04M21.71M21.98M21.96M45.62M65.04M
Cash, Cash Equivalents and Short-Term Investments64.44M21.27M21.73M21.19M42.29M64.44M
Total Debt0.000.000.000.000.000.00
Total Liabilities1.29M2.48M2.68M2.58M1.37M1.29M
Stockholders Equity63.75M19.23M19.21M19.38M44.25M63.75M
Cash Flow
Free Cash Flow-10.03M574.00K-3.49M-1.53M-24.44M-10.03M
Operating Cash Flow-8.27M574.00K-3.49M-1.53M-24.44M-8.27M
Investing Cash Flow-91.16M0.000.000.000.00-91.16M
Financing Cash Flow77.57M-228.00K-35.00K-1.04M-1.15M77.57M

Hygrovest Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
57
Neutral
AU$27.17M-12.067.64%3.28%0.13%-12.90%
54
Neutral
AU$10.27M39.601.34%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:UWC
Hygrovest Limited
0.05
<0.01
2.04%
CNGGF
Cann Group
0.02
0.00
0.00%
HDRPF
Epsilon Healthcare Limited
AU:LGP
Little Green Pharma Ltd.
0.11
-0.02
-15.38%
AU:VIT
Cronos Australia Ltd.
0.04
-0.03
-41.43%

Hygrovest Limited Corporate Events

Underwood Capital files half-year financials and Appendix 4D with ASX
Feb 26, 2026

Underwood Capital Limited has lodged its Appendix 4D and financial statements for the half year ended 31 December 2025 with the ASX, providing investors with updated insight into its financial performance and position. The release underscores the company’s ongoing mandate to deliver capital growth from listed and unlisted equities and debt securities, and offers stakeholders formal, regulator-aligned disclosure that will inform market assessment of its strategy and results.

The documentation filing marks a routine but important compliance step for the specialist investment company, ensuring transparency around portfolio outcomes and capital management over the period. For shareholders and potential investors, the half-year report serves as a key reference point for evaluating Underwood Capital’s execution against its investment objectives and its standing within the broader funds management sector.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital Reports January 2026 Portfolio Performance
Feb 11, 2026

Underwood Capital Limited has reported the performance of its investment portfolio for January 2026, fulfilling its disclosure obligations under ASX Listing Rule 4.12. The update reflects the company’s ongoing focus on transparent reporting around the performance of its listed and unlisted equity and debt investments, which is central to its strategy of delivering capital growth to shareholders.

The announcement reiterates that UWC’s results and future performance remain subject to various assumptions and market risks beyond its control. While confirming its commitment to shareholder value through portfolio management, the company cautions investors against relying on any specific return expectations and clarifies that the release does not constitute an offer or solicitation to buy or sell its securities, particularly in the United States.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital Reports December 2025 Portfolio Performance Update
Jan 11, 2026

Underwood Capital Limited has released its investment portfolio performance update for December 2025, providing investors with an overview of how its portfolio of listed and unlisted equities and debt securities fared over the month in line with disclosure requirements. The update underscores the company’s ongoing commitment to transparency around portfolio outcomes and risk, reinforcing its positioning as a specialist capital-growth manager for shareholders while highlighting that future performance remains subject to market and operational uncertainties.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital Limited Reports November 2025 Portfolio Performance
Dec 12, 2025

Underwood Capital Limited has released its investment portfolio performance for November 2025, highlighting its ongoing commitment to achieving medium-term capital growth for shareholders. The announcement underscores the company’s strategic focus on managing a diverse portfolio of equities and debt securities, which is crucial for its market positioning and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 03, 2026